These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6469200

  • 1. Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?
    Ascione A, Amitrano L, Riccio E, De Lella A, Canestrini C, de Bellis G, D'Alessandro R, Fiore R, Padulano P.
    Hepatogastroenterology; 1984 Jun; 31(3):123-4. PubMed ID: 6469200
    [Abstract] [Full Text] [Related]

  • 2. [Antiviral therapy of HBsAg positive chronic hepatitis: progress or erroneous development?].
    Hess G.
    Med Klin (Munich); 1987 May 15; 82(11):419-20. PubMed ID: 3600545
    [No Abstract] [Full Text] [Related]

  • 3. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S.
    Gastroenterology; 1981 May 15; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?
    Thakur V, Guptan RC, Malhotra V, Basir SF, Sarin SK.
    J Assoc Physicians India; 2002 Nov 15; 50():1386-94. PubMed ID: 12583467
    [Abstract] [Full Text] [Related]

  • 5. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R.
    Liver Transpl; 2001 Feb 15; 7(2):113-7. PubMed ID: 11172394
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A pilot study of long-term weekly interferon-beta administration for chronic hepatitis B.
    Kagawa T, Morizane T, Saito H, Tsunematsu S, Tada S, Kumagai N, Tsuchimoto K, Sugiura H, Mukai M, Tsuchiya M.
    Am J Gastroenterol; 1993 Feb 15; 88(2):212-6. PubMed ID: 8424423
    [Abstract] [Full Text] [Related]

  • 8. [Antiviral preparations in the therapy of chronic viral hepatitis].
    Geller LI.
    Ter Arkh; 1990 Feb 15; 62(11):15-9. PubMed ID: 1710074
    [Abstract] [Full Text] [Related]

  • 9. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y, Unoura M, Kato Y, Kobayashi K, Hattori N.
    Gan To Kagaku Ryoho; 1984 Feb 15; 11(2):205-11. PubMed ID: 6696458
    [Abstract] [Full Text] [Related]

  • 10. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB.
    Gastroenterology; 1981 Dec 15; 81(6):987-91. PubMed ID: 7286593
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
    Zoulim F, Capel F, Berthillon P, Trépo C, Petit MA.
    Gastroenterol Clin Biol; 1995 Dec 15; 19(12):970-5. PubMed ID: 8729407
    [Abstract] [Full Text] [Related]

  • 13. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.
    Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, Leung N, Luk JM, Lie AK, Kwong YL, Liang R, Lau GK.
    Gastroenterology; 2006 Jul 15; 131(1):59-68. PubMed ID: 16831590
    [Abstract] [Full Text] [Related]

  • 14. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
    Niigaki M, Fukuda R, Hamamoto S, Ishimura N, Ishihara S, Akagi S, Watanabe M, Kinoshita Y.
    Am J Gastroenterol; 2000 Jan 15; 95(1):239-47. PubMed ID: 10638591
    [Abstract] [Full Text] [Related]

  • 15. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B.
    Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH.
    Hepatology; 1993 Dec 15; 18(6):1313-8. PubMed ID: 8244254
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
    Cianciara J, Loch T, Babiuch L, Dabrowska-Bernstein B, Stasiak A, Dabrowski M, Pawińska A.
    Pol Tyg Lek; 1988 Sep 12; 43(37):1195-8. PubMed ID: 2470069
    [No Abstract] [Full Text] [Related]

  • 17. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY, Huh W, Lee DH, Choi MS, Lee JH, Koh KC, Kim SJ, Joh JW, Oh HY.
    Transplant Proc; 2007 Dec 12; 39(10):3121-6. PubMed ID: 18089336
    [Abstract] [Full Text] [Related]

  • 18. [Management of chronic hepatitis B].
    Telegdy L.
    Orv Hetil; 1997 Jun 01; 138(22 Suppl 1):1462-5. PubMed ID: 9221375
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC, Yulugkural Z, Vahaboglu H.
    Chemotherapy; 2007 Jun 01; 53(6):402-6. PubMed ID: 17934260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.